Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Concussion Awareness and Education Act of 2019
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R. 280, Concussion Awareness and Education Act FTC Reauthorization Act of 2020 (Not introduced)
Concussion Awareness and Education Act of 2019
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R. 280, Concussion Awareness and Education Act FTC Reauthorization Act of 2020 (Not introduced)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE ADVERTISING COALITION via POLSINELLI PC
2020 · fourth_quarter · 4T
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2020 · third_quarter · Q3
Source: Senate LDA
| CBS CORPORATION |
| 34 |
| 2008–2015 |
| GROCERY MANUFACTURERS ASSOCIATION | 34 | 2008–2015 |
| NATIONAL ASSOCIATION OF BROADCASTERS | 34 | 2008–2015 |
| NATIONAL CABLE TELECOMMUNICATIONS ASSOCIATION | 34 | 2008–2015 |
| UNIVERSITY OF KANSAS HOSPITAL AUTHORITY | 30 | 2008–2015 |
| WALT DISNEY COMPANY THE | 29 | 2009–2015 |
| NBC UNIVERSAL | 26 | 2009–2015 |
| Time Warner Inc. | 23 | 2009–2014 |
| THE ADVERTISING COALITION | 22 | 2016–2020 |
| MAGAZINE PUBLISHERS OF AMERICA | 17 | 2008–2015 |
| NATIONAL BIO AND AGRO DEFENSE FACILITY IN KANSAS STEERING COMMITTEE | 14 | 2012–2015 |
| HEALTHY ADVICE NETWORKS | 13 | 2008–2011 |
| THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 13 | 2012–2014 |
| PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA | 10 | 2008–2010 |
| QUEST DIAGNOSTICS | 10 | 2016–2017 |
| POLSINELLI SHALTON FLANIGAN SUELTHAUS PC | 7 | 2007–2008 |
| TEVA PHARMACEUTICALS USA INC | 6 | 2019–2020 |
| VIACOM | 4 | 2015 |
| COMCAST CORPORATION | 3 | 2015 |
| HOMES FOR AMERICA ALLIANCE, INC. | 3 | 2009 |
| INTERACTIVE ADVERTISING BUREAU | 3 | 2015 |
| TWENTY-FIRST CENTURY FOX, INC. | 3 | 2015 |
| AMERICAN ASSOCIATION FOR HEALTH FREEDOM | 2 | 2008 |
| AMERICAN COMPOSITES MANUFACTURERS ASSOCIATION | 2 | 2014 |
| BELO CORPORATION | 2 | 2007 |
| BENNETT COLLEGE | 2 | 2007 |
| FLORIDA MEMORIAL UNIVERSITY | 2 | 2007 |
| HYPERION RESOURCES INC | 2 | 2007 |
| JACKSON STATE UNIVERSITY | 2 | 2007 |
| PARK UNIVERSITY | 2 | 2007 |
| PEROT SYSTEMS GOVERNMENT SERVICES | 2 | 2007 |
| SICKLE CELL DISEASE ASSOCIATION OF AMERICA | 2 | 2007 |
| UNITED NEGRO COLLEGE FUND INC | 2 | 2007 |
| AMERICA VOTES | 1 | 2007 |
| CHICAGO STATE UNIVERSITY | 1 | 2007 |
| MANNATECH INC | 1 | 2007 |
| NATIONAL ASSOCIATION OF SOCIAL WORKERS | 1 | 2007 |
| SPELMAN COLLEGE | 1 | 2007 |
Elijah E. Cummings Lower Drug Costs Now Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing policies
Elijah E. Cummings Lower Drug Costs Now Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
Elijah E. Cummings Lower Drug Costs Now Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing policies
Elijah E. Cummings Lower Drug Costs Now Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
Responsibility in Drug Advertising Act of 2019
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Responsibility in Drug Advertising Act of 2019
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Responsibility in Drug Advertising Act of 2019
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Responsibility in Drug Advertising Act of 2019
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
Families First Coronavirus Response Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
Families First Coronavirus Response Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
Drug-price Transparency in Communications (DTC) Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Drug-price Transparency in Communications (DTC) Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Drug-price Transparency in Communications (DTC) Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Drug-price Transparency in Communications (DTC) Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing policies
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing policies
Prescription Drug Pricing Reduction Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
Prescription Drug Pricing Reduction Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing policies
Prescription Drug Pricing Reduction Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing policies
Prescription Drug Pricing Reduction Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
No Tax Subsidies for E-Cigarette and Tobacco Ads Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
No Tax Subsidies for E-Cigarette and Tobacco Ads Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
No Tax Subsidies for E-Cigarette and Tobacco Ads Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
No Tax Subsidies for E-Cigarette and Tobacco Ads Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
H.R.280, Concussion Awareness and Education Act H.J.Res.31, Consolidated Appropriations Act 2019 FTC Reauthorization Act of 2019 (Not introduced)
H.R.280, Concussion Awareness and Education Act H.R.1158, FY2020 Consolidated Appropriations Act H.R.1865, FY2020 Further Consolidated Appropriations Act FTC Reauthorization Act of 2019 (Not introduced)
Protecting Consumer Access to Generic Drugs Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Protecting Consumer Access to Generic Drugs Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Orange Book Transparency Act of 2020
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Orange Book Transparency Act of 2020
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Further Extension of Continuing Appropriations Act, 2021
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Further Extension of Continuing Appropriations Act, 2021
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Further Consolidated Appropriations Act, 2020
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R.280, Concussion Awareness and Education Act H.R.1158, FY2020 Consolidated Appropriations Act H.R.1865, FY2020 Further Consolidated Appropriations Act FTC Reauthorization Act of 2019 (Not introduced)
Further Consolidated Appropriations Act, 2020
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
Further Consolidated Appropriations Act, 2020
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
More Efficient Tools to Realize Information for Consumers Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
More Efficient Tools to Realize Information for Consumers Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Prescription Pricing for the People Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Prescription Pricing for the People Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R.280, Concussion Awareness and Education Act H.R.2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 FTC Reauthorization Act of 2019 (Not introduced)
Concussion Awareness and Education Act of 2019
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R.280, Concussion Awareness and Education Act H.J.Res.31, Consolidated Appropriations Act 2019 FTC Reauthorization Act of 2019 (Not introduced)
Concussion Awareness and Education Act of 2019
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R.280, Concussion Awareness and Education Act H.R.1158, FY2020 Consolidated Appropriations Act H.R.1865, FY2020 Further Consolidated Appropriations Act FTC Reauthorization Act of 2019 (Not introduced)
Concussion Awareness and Education Act of 2019
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R.280, Concussion Awareness and Education Act H.R.2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 FTC Reauthorization Act of 2019 (Not introduced)
Concussion Awareness and Education Act of 2019
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R.280, Concussion Awareness and Education Act H.R.4378, FY2020 Continuing Appropriations Resolution S.2584, FY2020 Commerce, Justice, Science, and Related Agencies Appropriations Act FTC Reauthorization Act of 2019 (Not introduced)
Elijah E. Cummings Lower Drug Costs Now Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
Elijah E. Cummings Lower Drug Costs Now Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
Elijah E. Cummings Lower Drug Costs Now Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
Elijah E. Cummings Lower Drug Costs Now Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
Responsibility in Drug Advertising Act of 2019
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R. 4106, Responsibility in Drug Advertising Act
Responsibility in Drug Advertising Act of 2019
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Client: RIDDELL SPORTS, INC. · Firm: POLSINELLI PC
H.R.280, Concussion Awareness and Education Act H.R.4378, FY2020 Continuing Appropriations Resolution S.2584, FY2020 Commerce, Justice, Science, and Related Agencies Appropriations Act FTC Reauthorization Act of 2019 (Not introduced)
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Prescription Pricing for the People Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Prescription Pricing for the People Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Affordable Prescriptions for Patients Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Affordable Prescriptions for Patients Act of 2019
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: POLSINELLI PC
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
Drug-price Transparency in Communications (DTC) Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R. 4106, Responsibility in Drug Advertising Act
Drug-price Transparency in Communications (DTC) Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Drug-price Transparency in Communications (DTC) Act
Client: THE ADVERTISING COALITION · Firm: POLSINELLI PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2020 · second_quarter · Q2
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via POLSINELLI PC
2020 · second_quarter · Q2
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing policies
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2020 · second_quarter · Q2
H.R. 280, Concussion Awareness and Education Act FTC Reauthorization Act of 2020 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2020 · first_quarter · Q1
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via POLSINELLI PC
2020 · first_quarter · Q1
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act Review of Administration drug pricing policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2020 · first_quarter · Q1
H.R. 280, Concussion Awareness and Education Act FTC Reauthorization Act of 2020 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via POLSINELLI PC
2019 · fourth_quarter · Q4
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2019 · fourth_quarter · Q4
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2019 · fourth_quarter · Q4
H.R.280, Concussion Awareness and Education Act H.R.1158, FY2020 Consolidated Appropriations Act H.R.1865, FY2020 Further Consolidated Appropriations Act FTC Reauthorization Act of 2019 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via POLSINELLI PC
2019 · third_quarter · Q3
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2019 · third_quarter · Q3
H.R.280, Concussion Awareness and Education Act H.R.4378, FY2020 Continuing Appropriations Resolution S.2584, FY2020 Commerce, Justice, Science, and Related Agencies Appropriations Act FTC Reauthorization Act of 2019 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2019 · third_quarter · Q3
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R. 4106, Responsibility in Drug Advertising Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via POLSINELLI PC
2019 · second_quarter · Q2
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
H.R.938, Bringing Low Cost Options & Competition While Keeping Incentives for New Generics (BLOCKING) Act H.R.965/ S.340, CREATES Act H.R.1503, Orange Book Transparency Act H.R.1520, Purple Book Continuity Act H.R.2374/ S.1224, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2376/ S.1227, Prescription Pricing for the People Act S.1416, Affordable Prescriptions for Patients Act S.1895, Lower Health Care Costs Act H.R. 1499, Protecting Consumer Access to Generic Drugs Act Administration review of drug pricing policies
RIDDELL SPORTS, INC. via POLSINELLI PC
2019 · second_quarter · Q2
H.R.280, Concussion Awareness and Education Act H.R.2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 FTC Reauthorization Act of 2019 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2019 · second_quarter · Q2
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via POLSINELLI PC
2019 · second_quarter · RR
Issues pertaining to pharmaceutical and healthcare markets
Issues pertaining to pharmaceutical and healthcare markets
Issues pertaining to pharmaceutical and healthcare markets
RIDDELL SPORTS, INC. via POLSINELLI PC
2019 · first_quarter · Q1
H.R.280, Concussion Awareness and Education Act H.J.Res.31, Consolidated Appropriations Act 2019 FTC Reauthorization Act of 2019 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2019 · first_quarter · Q1
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2018 · fourth_quarter · Q4
S. 3107/H.R. 6258, FY18 Financial Services and General Government Appropriations Act FTC Reauthorization Act of 2018 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2018 · fourth_quarter · Q4
H.R. 2360, Concussion Awareness and Education Act FTC Reauthorization Act of 2018 (Not introduced) H.R. 5952/S. 3072, FY19 Commerce-Justice-Science Appropriations Act H.R. 6615/S. 3657, Traumatic Brain Injury Program Reauthorization Act H.R. 3580/ S. 3686, Protecting Student Athletes from Concussions Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2018 · fourth_quarter · Q4
H.R.1776/ S.771, Improving Access To Affordable Prescription Drugs Act H.R. 2439/ S.1131, Fair Accountability and Innovative Research Drug Pricing Act S.1348, Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act H.R.4385, Responsibility in Drug Advertising Act H.R.4116, Transparent Drug Pricing Act S.2157, Drug-Price Transparency in Communications Act S.2478, End Taxpayer Subsidies for Drug Ads Act FTC Reauthorization Act of 2018 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2018 · third_quarter · Q3
H.R. 2360, Concussion Awareness and Education Act FTC Reauthorization Act of 2018 (Not introduced) H.R. 5952/S. 3072, FY19 Commerce-Justice-Science Appropriations Act H.R.6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2018 · third_quarter · Q3
H.R.1776/ S.771, Improving Access To Affordable Prescription Drugs Act H.R. 2439/ S.1131, Fair Accountability and Innovative Research Drug Pricing Act S.1348, Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act H.R.4385, Responsibility in Drug Advertising Act H.R.4116, Transparent Drug Pricing Act S.2157, Drug-Price Transparency in Communications Act S.2478, End Taxpayer Subsidies for Drug Ads Act FTC Reauthorization Act of 2018 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2018 · third_quarter · Q3
S. 3107/H.R. 6258, FY18 Financial Services and General Government Appropriations Act FTC Reauthorization Act of 2018 (Not introduced) H.R.6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2018 · second_quarter · Q2
H.R. 1625, Consolidated Appropriations Act H.R. 2360, Concussion Awareness and Education Act FTC Reauthorization Act of 2018 (Not introduced) S. 3072, FY18 Commerce-Justice-Science Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2018 · second_quarter · Q2
S. 3107/H.R. 6258, FY18 Financial Services and General Government Appropriations Act FTC Reauthorization Act of 2018 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2018 · second_quarter · Q2
H.R.1776/ S.771, Improving Access To Affordable Prescription Drugs Act H.R. 2439/ S.1131, Fair Accountability and Innovative Research Drug Pricing Act S.1348, Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act H.R.4385, Responsibility in Drug Advertising Act H.R.4116, Transparent Drug Pricing Act S.2157, Drug-Price Transparency in Communications Act S.2478, End Taxpayer Subsidies for Drug Ads Act FTC Reauthorization Act of 2018 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2018 · first_quarter · Q1
H.R.1776/ S.771, Improving Access To Affordable Prescription Drugs Act H.R. 2439/ S.1131, Fair Accountability and Innovative Research Drug Pricing Act S.1348, Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act H.R.4385, Responsibility in Drug Advertising Act H.R.4116, Transparent Drug Pricing Act S.2157, Drug-Price Transparency in Communications Act S.2478, End Taxpayer Subsidies for Drug Ads Act FTC Reauthorization Act of 2018 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2018 · first_quarter · Q1
H.R. 1625, Consolidated Appropriations Act H.R. 2360, Concussion Awareness and Education Act FTC Reauthorization Act of 2018 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2018 · first_quarter · Q1
H.R.195/1892/1301 (Continuing Resolution) H.R. 1625, Consolidated Appropriations Act FTC Reauthorization Act of 2018 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2017 · fourth_quarter · Q4
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018 H.R. 601, Continuing Appropriations Act, 2018 Medicare reimbursement related to the Protecting Access to Medicare Act of 2014
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2017 · fourth_quarter · Q4
H.J.Res.123, Making further continuing appropriations for fiscal year 2018, and for other purposes H.R.1370 (Continuing Resolution) H.R. 2360, Concussion Awareness and Education Act FTC Reauthorization Act of 2017 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2017 · fourth_quarter · Q4
FTC Reauthorization Act of 2017 (Not introduced) H.J.Res.123, Making further continuing appropriations for fiscal year 2018, and for other purposes H.R.1370 (Continuing Resolution) Senate FY2018 Financial Services & General Government Appropriations Bill (Draft)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2017 · fourth_quarter · Q4
H.R. 1, An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 H.R.1776/ S.771, Improving Access To Affordable Prescription Drugs Act H.R. 2439/ S.1131, Fair Accountability and Innovative Research Drug Pricing Act S.1348, Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act H.R.4385, Responsibility in Drug Advertising Act H.R.4116, Transparent Drug Pricing Act S.2157, Drug-Price Transparency in Communications Act FTC Reauthorization Act of 2017 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2017 · third_quarter · Q3
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018 H.R. 601, Continuing Appropriations Act, 2018 Medicare reimbursement related to the Protecting Access to Medicare Act of 2014
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2017 · third_quarter · Q3
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018 H.R. 601, Continuing Appropriations Act, 2018 H.R. 2360, Concussion Awareness and Education Act FTC Reauthorization Act of 2017 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
THE ADVERTISING COALITION via POLSINELLI PC
2017 · third_quarter · Q3
A bill providing for comprehensive tax reform (not introduced) H.R.1776/S.771 Improving Access To Affordable Prescription Drugs Act H.R.2439/S.1131 Fair Accountability and Innovative Research Drug Pricing Act S.1348 Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act FTC Reauthorization Act of 2017 (not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2017 · third_quarter · Q3
FTC Reauthorization Act of 2017 (Not introduced) H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018 H.R. 601, Continuing Appropriations Act, 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
QUEST DIAGNOSTICS via POLSINELLI PC
2017 · second_quarter · Q2
H.R.244, Consolidated Appropriations Act FY18 Agriculture, Rural Development, Food and Drug Administration Appropriations Act Medicare reimbursement related to the Protecting Access to Medicare Act of 2014 H.R.1628, American Health Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2017 · second_quarter · Q2
H.R.244, Consolidated Appropriations Act FY18 Financial Services and General Government Appropriations Act FY18 Labor/HHS/Education Appropriations Act FY18 CJS Appropriations Act H.R. 2360, Concussion Awareness and Education Act FTC Reauthorization Act of 2017 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2017 · second_quarter · Q2
FTC Reauthorization Act of 2017 (Not introduced) H.R.244, Consolidated Appropriations Act FY18 Financial Services and General Government Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2017 · second_quarter · Q2
A bill providing for comprehensive tax reform (not introduced) H.R.1776/S.771 Improving Access To Affordable Prescription Drugs Act H.R.2439/S.1131 Fair Accountability and Innovative Research Drug Pricing Act S.1348 Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act FTC Reauthorization Act of 2017 (not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2017 · first_quarter · Q1
FY17/FY18 Agriculture, Rural Development, Food and Drug Administration Appropriations Act Medicare reimbursement related to the Protecting Access to Medicare Act of 2014
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2017 · first_quarter · Q1
FY17/FY18 Financial Services and General Government Appropriations Act FY17/FY18 Labor/HHS/Education Appropriations Act FY17/FY18 CJS Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2017 · first_quarter · Q1
FTC Reauthorization Act of 2017 (Not introduced) FY17/FY18 Financial Services and General Government Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2017 · first_quarter · Q1
A bill providing for comprehensive tax reform (Not introduced) H.R.1776, Improving Access To Affordable Prescription Drugs Act S.771, Improving Access To Affordable Prescription Drugs Act FTC Reauthorization Act of 2017 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2016 · fourth_quarter · Q4
H.R. 6, 21st Century Cures Act Medicare reimbursement related to the Protecting Access to Medicare Act of 2014 H.R. 2028, Further Continuing and Security Assistance Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2016 · fourth_quarter · Q4
H.R. 1271, Concussion Awareness and Education Act of 2015 H.R. 1420, National Traumatic Brain Injury Research and Treatment Improvement Act of 2015 H.R. 582/S. 307, Concussion Treatment and Care Tools Act of 2015 H. Res. 112/S. Res. 83, Supporting the goals and ideals of the Secondary School Student Athletes Bill of Rights H.R. 2932, PLAYS in Youth Sports Act H.R. 2062/S. 988, Protecting Student Athletes from Concussions Act S. 2508/H.R. 4460 Youth Sports Concussion Act H.R. 2028, Further Continuing and Security Assistance Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2016 · fourth_quarter · Q4
H.R. 5232/S. 2936, Stop Subsidizing Childhood Obesity Act H.R. 2028, Further Continuing and Security Assistance Appropriations Act FTC Reauthorization Act of 2016 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2016 · fourth_quarter · Q4
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act H.R. 6043/S. 3335, FAIR Drug Pricing Act FTC Reauthorization Act of 2016 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2016 · third_quarter · Q3
H.R. 5054/S. 2956, FY17 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act H.R. 6, 21st Century Cures Act Medicare reimbursement related to the Protecting Access to Medicare Act of 2014 H.R. 5926/S. 3040, FY17 Labor/HHS/Education Appropriations Act H.R.5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2016 · third_quarter · Q3
H.R. 1271, Concussion Awareness and Education Act of 2015 H.R. 1420, National Traumatic Brain Injury Research and Treatment Improvement Act of 2015 H.R. 582/S. 307, Concussion Treatment and Care Tools Act of 2015 H. Res. 112/S. Res. 83, Supporting the goals and ideals of the Secondary School Student Athletes Bill of Rights H.R. 2932, PLAYS in Youth Sports Act H.R. 2062/S. 988, Protecting Student Athletes from Concussions Act S. 2508/H.R. 4460 Youth Sports Concussion Act S. 3067 FY 17 Financial Services & General Government Appropriations Act S. 3040 FY 17 Labor/HHS/Education Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2016 · third_quarter · Q3
H.R. 5232/S. 2936, Stop Subsidizing Childhood Obesity Act H.R. 5485/S. 3067, FY17 Financial Services & General Government Appropriations Act H.R.5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act FTC Reauthorization Act of 2016 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2016 · third_quarter · Q3
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act FTC Reauthorization Act of 2016 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2016 · first_quarter · Q1
FDA regulation of laboratory developed tests HR 6, 21st Century Cures Act Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2016 · second_quarter · 2A
H.R. 5054/S. 2956, FY17 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act H.R. 6, 21st Century Cures Act Medicare reimbursement related to the Protecting Access to Medicare Act of 2014 H.R. XXXX/S. 3040, FY17 Labor/HHS/Education Appropriations Act H.R. 2577, FY17 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2016 · second_quarter · Q2
H.R. 5054/S. 2956, FY17 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act H.R. 6, 21st Century Cures Act Medicare reimbursement related to the Protecting Access to Medicare Act of 2014 H.R. XXXX/S. 3040, FY17 Labor/HHS/Education Appropriations Act H.R. 2577, FY17 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2016 · second_quarter · Q2
H.R. 1271, Concussion Awareness and Education Act of 2015 H.R. 1420, National Traumatic Brain Injury Research and Treatment Improvement Act of 2015 H.R. 582/S. 307, Concussion Treatment and Care Tools Act of 2015 H. Res. 112/S. Res. 83, Supporting the goals and ideals of the Secondary School Student Athletes Bill of Rights H.R. 2932, PLAYS in Youth Sports Act H.R. 2062/S. 988, Protecting Student Athletes from Concussions Act S. 2508/H.R. 4460 Youth Sports Concussion Act S. 3067 FY 17 Financial Services & General Government Appropriations Act S. 3040 FY 17 Labor/HHS/Education Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2016 · second_quarter · Q2
A bill providing for comprehensive tax reform (Not yet introduced) H.R. 5232/S. 2936, Stop Subsidizing Childhood Obesity Act H.R. 5485/S. 3067, FY17 Financial Services & General Government Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2016 · second_quarter · Q2
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act FTC Reauthorization Act of 2016 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2016 · first_quarter · 1A
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act FTC Reauthorization Act of 2016 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2016 · first_quarter · Q1
H.R. 1271, Concussion Awareness and Education Act of 2015 H.R. 1420, National Traumatic Brain Injury Research and Treatment Improvement Act of 2015 H.R. 582/S. 307, Concussion Treatment and Care Tools Act of 2015 H. Res. 112/S. Res. 83, Supporting the goals and ideals of the Secondary School Student Athletes Bill of Rights H.R. 2932, PLAYS in Youth Sports Act H.R. 2062/S. 988, Protecting Student Athletes from Concussions Act S. 2508/H.R. 4460 Youth Sports Concussion Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2016 · first_quarter · Q1
A bill providing for comprehensive tax reform (Not yet introduced) FY 17 Financial Services & General Government Appropriations Act (Not introduced) FTC Reauthorization Act of 2015 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ADVERTISING COALITION via POLSINELLI PC
2016 · first_quarter · Q1
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 4565, Responsibility in Drug Advertising Act of 2016 S. 2623, Protecting Americans from Drug Marketing Act FTC Reauthorization Act of 2016 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via POLSINELLI PC
2016 · first_quarter · RR
Health care, medicare and medicaid issues, the implementation of the Protecting Access to Medicare Act, legislation regarding the regulation of laboratory developed tests.
THE ADVERTISING COALITION via POLSINELLI PC
2016 · first_quarter · RR
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 FTC Reauthorization Act of 2015 (Not introduced)
RIDDELL SPORTS, INC. via POLSINELLI PC
2015 · fourth_quarter · Q4
H.R. 1271, Concussion Awareness and Education Act of 2015 H.R. 1420, National Traumatic Brain Injury Research and Treatment Improvement Act of 2015 H.R. 582/S. 307, Concussion Treatment and Care Tools Act of 2015 H. Res. 112/S. Res. 83, Supporting the goals and ideals of the Secondary School Student Athletes Bill of Rights H.R. 2932, PLAYS in Youth Sports Act H.R. 2062/S. 988, Protecting Student Athletes from Concussions Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2015 · fourth_quarter · Q4
A bill providing for comprehensive tax reform (Not yet introduced) H.R. 2029, Consolidated Appropriations Act FTC Reauthorization Act of 2015 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE WALT DISNEY COMPANY via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIACOM via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CBS CORPORATION via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CABLE & TELECOMMUNICATIONS ASSOCIATION via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BROADCASTERS via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEWSPAPER ASSOCIATION OF AMERICA via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GROCERY MANUFACTURERS ASSOCIATION via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF NATIONAL ADVERTISERS via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF ADVERTISING AGENCIES via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ADVERTISING FEDERATION via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via POLSINELLI PC
2015 · fourth_quarter · 4T
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 FTC Reauthorization Act of 2015 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERACTIVE ADVERTISING BUREAU via POLSINELLI PC
2015 · fourth_quarter · 4T
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 FTC Reauthorization Act of 2015 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGAZINE PUBLISHERS OF AMERICA via POLSINELLI PC
2015 · fourth_quarter · 4T
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TWENTY-FIRST CENTURY FOX, INC. via POLSINELLI PC
2015 · fourth_quarter · 4T
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 FTC Reauthorization Act of 2015 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TWENTY-FIRST CENTURY FOX, INC. via POLSINELLI PC
2015 · third_quarter · Q3
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 FTC Reauthorization Act of 2015 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIDDELL SPORTS, INC. via POLSINELLI PC
2015 · third_quarter · Q3
H.R. 1271, Concussion Awareness and Education Act of 2015 H.R. 1420, National Traumatic Brain Injury Research and Treatment Improvement Act of 2015 H.R. 582/S. 307, Concussion Treatment and Care Tools Act of 2015 H. Res. 112/S. Res. 83, Supporting the goals and ideals of the Secondary School Student Athletes Bill of Rights H.R. 2932, PLAYS in Youth Sports Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AMERICAN ADVERTISING via POLSINELLI PC
2015 · third_quarter · Q3
A bill providing for comprehensive tax reform (Not yet introduced) FY16 Financial Services Appropriations Act HR 719 (FY 2016 continuing appropriations) FTC Reauthorization Act of 2015 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TWENTY-FIRST CENTURY FOX, INC. via POLSINELLI PC
2015 · third_quarter · RR
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 FTC Reauthorization Act of 2015 (Not introduced)
THE WALT DISNEY COMPANY via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIACOM via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CBS CORPORATION via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGAZINE PUBLISHERS OF AMERICA via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CABLE & TELECOMMUNICATIONS ASSOCIATION via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BROADCASTERS via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEWSPAPER ASSOCIATION OF AMERICA via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GROCERY MANUFACTURERS ASSOCIATION via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF NATIONAL ADVERTISERS via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF ADVERTISING AGENCIES via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ADVERTISING FEDERATION via POLSINELLI PC
2015 · third_quarter · Q3
FTC Reauthorization Act of 2015 (Not introduced) A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via POLSINELLI PC
2015 · third_quarter · Q3
A bill providing for comprehensive tax reform (Not introduced) H.R. 1741, Truth in Healthcare Marketing Act of 2015 FTC Reauthorization Act of 2015 (Not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to pharmaceutical and healthcare markets